We are live on ! Find out more
PAMP

Polar Asset Management Partners Portfolio holdings

AUM $5.01B
1-Year Est. Return 35.02%
This Fund
S&P 500
This Quarter Est. Return
+10.31%
1 Year Est. Return
+35.02%
3 Year Est. Return
+91.93%
5 Year Est. Return
+123.34%
10 Year Est. Return
+317%
AUM
$5.79B
AUM Growth
+$1.29B
Cap. Flow
+$15.7M
Cap. Flow %
0.27%
Top 10 Hldgs %
39.16%
Holding
1,044
New
179
Increased
54
Reduced
138
Closed
256

Sector Composition

Rank Sector Weight
1 Technology 10.94%
2 Healthcare 7.71%
3 Financials 6.11%
4 Industrials 5.82%
5 Consumer Discretionary 3.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LVS icon
226
Las Vegas Sands
LVS
$29.6B
$4.21M 0.07%
85,500
-237,900
-74% -$11.2M
ALCY
227
DELISTED
Alchemy Investments Acquisition Corp 1
ALCY
$4.17M 0.07%
400,000
-100,000
-20% -$1.04M
APG icon
228
APi Group
APG
$18B
$4.12M 0.07%
+178,650
New +$3.44M
APXI
229
DELISTED
APx Acquisition Corp. I Class A Ordinary Share
APXI
$4.11M 0.07%
367,500
KO icon
230
Coca-Cola
KO
$375B
$4.07M 0.07%
+69,000
New +$3.92M
ONON icon
231
CALL
On Holding
ONON
$12.5B
$4.05M 0.07%
+150,000
New +$4.09M
KLG
232
DELISTED
WK Kellogg Co
KLG
$4.03M 0.07%
+306,428
New +$3.45M
CVE icon
233
Cenovus Energy
CVE
$52.1B
$4M 0.07%
240,001
+95,501
+66% +$1.75M
LATG
234
DELISTED
Chenghe Acquisition I Co. Class A Ordinary Shares
LATG
$3.97M 0.07%
+360,000
New +$3.95M
BLFS icon
235
BioLife Solutions
BLFS
$1.7B
$3.93M 0.07%
+241,600
New +$3.08M
SRPT icon
236
Sarepta Therapeutics
SRPT
$1.77B
$3.86M 0.07%
40,000
+15,700
+65% +$1.51M
INCY icon
237
Incyte
INCY
$24.4B
$3.79M 0.07%
+60,400
New +$3.42M
KVAC
238
DELISTED
Keen Vision Acquisition Corp
KVAC
$3.79M 0.07%
367,000
GLBE icon
239
Global E Online
GLBE
$7.11B
$3.79M 0.07%
+95,600
New +$3.44M
CLDX icon
240
Celldex Therapeutics
CLDX
$3.28B
$3.74M 0.06%
94,300
-38,100
-29% -$1.12M
ABP
241
DELISTED
Abpro Holdings
ABP
$3.74M 0.06%
11,667
PORT
242
DELISTED
Southport Acquisition Corporation
PORT
$3.72M 0.06%
350,000
-350,000
-50% -$3.71M
ATLX icon
243
Atlas Lithium Corp
ATLX
$91.7M
$3.72M 0.06%
118,776
+82,451
+227% +$2.14M
FERG icon
244
Ferguson
FERG
$49.8B
$3.71M 0.06%
19,200
-20,200
-51% -$3.41M
TGAN
245
DELISTED
Transphorm, Inc. Common Stock
TGAN
$3.69M 0.06%
1,009,702
SBDS
246
DELISTED
Solo Brands Inc
SBDS
$3.65M 0.06%
14,798
-8,540
-37% -$1.66M
NEM icon
247
Newmont
NEM
$119B
$3.62M 0.06%
87,400
-6,793
-7% -$262K
BIDU icon
248
PUT
Baidu
BIDU
$37.2B
$3.57M 0.06%
+30,000
New +$3.47M
AMLX icon
249
Amylyx Pharmaceuticals
AMLX
$2.54B
$3.57M 0.06%
242,300
+210,300
+657% +$3.22M
FMC icon
250
FMC
FMC
$1.33B
$3.56M 0.06%
+56,500
New +$3.28M

Similar funds

Polar Asset Management Partners's Q4 2023 Portfolio in Review

As of Q4 2023, Polar Asset Management Partners held 1,044 positions worth $5.79B, up 29% from $4.5B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Polar Asset Management Partners's Q4 2023 filing shows 179 new, 54 increased, 138 reduced and 256 closed positions. Its largest new stake was Pioneer Natural Resource Co.: 159,000 shares worth $35.8M. The largest sale was Activision Blizzard, an estimated $52.4M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.

  • Polar Asset Management Partners's largest Q4 2023 buy was Pioneer Natural Resource Co.: 159,000 shares worth $35.8M.
  • Polar Asset Management Partners added most to Splunk Inc in Q4 2023, an estimated $22.8M increase.
  • Polar Asset Management Partners's biggest Q4 2023 reduction was NVIDIA, cutting an estimated $50.1M.
  • Polar Asset Management Partners fully exited Activision Blizzard in Q4 2023, selling an estimated $52.4M.
  • Polar Asset Management Partners's ten largest holdings make up 39% of its $5.79B portfolio in Q4 2023.
  • Polar Asset Management Partners opened 179 new positions and closed 256 in Q4 2023.
  • Polar Asset Management Partners's portfolio value rose 29% quarter-over-quarter to $5.79B.

Based on Polar Asset Management Partners's 13F filing for Q4 2023, filed 14 Feb 2024.